Cart
sales@molnova.com
Xanthine oxidoreductase-IN-4
CAS No. 1026587-58-5
Xanthine oxidoreductase-IN-4( —— )
Catalog No. M36437 CAS No. 1026587-58-5
Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 96 | Get Quote |
|
| 5MG | 136 | Get Quote |
|
| 10MG | 201 | Get Quote |
|
| 25MG | 332 | Get Quote |
|
| 50MG | 505 | Get Quote |
|
| 100MG | 710 | Get Quote |
|
| 500MG | 1467 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameXanthine oxidoreductase-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionXanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.
-
DescriptionXanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor. Xanthine oxidoreductase-IN-4 has inhibitory activity against XOR with an IC50 value of 29.3 nM. Xanthine oxidoreductase-IN-4 can be used for the research of hyperuricemia.
-
In Vitro——
-
In VivoAnimal Model:Mice acute hyperuricemia modelDosage:5 mg/kg Administration:Oral Result:Reduced serum levels of uric acid significantly from 4 h after administration.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetXanthine Oxidase (XAO)
-
RecptorXanthine Oxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1026587-58-5
-
Formula Weight309.32
-
Molecular FormulaC16H15N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1=CC=C(OCC)C=C1)(=O)C2=CC=C(C=C2)C=3NN=NN3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wen Peng, et al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947. ?
molnova catalog
related products
-
Tigulixostat
Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.
-
Purpurogallin
Purpurogallin is a naturally phenol extracted from the plants of Quercus spp.
-
Benzbromarone
A uricosuric agent and non-competitive inhibitor of xanthine oxidase (Ki=8.5 uM); also has potentcy for CYP2C9; also blocks calcium-activated chloride channel (CaCC) TMEM16A with IC50 of 9.97 uM in HEK293 cells.
